Category: Include on Menu

Shares of Liberty Energy Inc. (NYSE:LBRT) dropped about 5.75% on Wednesday after the company revealed plans to issue $450 million in convertible senior notes. The oilfield services provider said the notes, which will mature in 2032, will be offered through a private placement to qualified institutional buyers. Liberty also expects to give the initial purchasers…

BrightView (NYSE:BV) announced an expansion of its sports field and golf course maintenance operations, pointing to a series of recent projects at prominent venues and major sporting events in the United States and abroad. The commercial landscaping provider serves as the Official Field Consultant of Major League Baseball and has supported more than 200 international…

Anavex Life Sciences Corp. (NASDAQ:AVXL) has withdrawn its application for European Union marketing authorization for blarcamesine as an add-on treatment for early Alzheimer’s disease. The decision follows feedback from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) indicating that the application was unlikely to receive a favorable opinion. The biotechnology company…

Shares of Enliven Therapeutics (NASDAQ:ELVN) climbed 28% on Wednesday following news that Merck (NYSE:MRK) plans to acquire oncology-focused Terns Pharmaceuticals in a $6.7 billion transaction. Maze Therapeutics (NASDAQ:MAZE) also moved higher, rising about 10%. Merck announced Wednesday that it will purchase clinical-stage oncology company Terns Pharmaceuticals for $53.00 per share in cash, valuing the company’s…

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM) gained about 8% on Wednesday after the company released updated results from its ongoing Phase 1/2 clinical study of BEAM-302, a treatment being developed for alpha-1 antitrypsin deficiency (AATD). According to the company, patients receiving a 60 mg dose of BEAM-302 achieved a mean steady-state total AAT level of…

Shares of Nanobiotix (NASDAQ:NBTX) climbed sharply after media reports suggested that Johnson & Johnson (NYSE:JNJ) is evaluating a potential acquisition of the French biotech firm. According to La Lettre, J&J is reviewing the possibility of buying Nanobiotix, a company it already collaborates with on the development of a cancer treatment. Neither Johnson & Johnson nor…

U.S. import prices rose far more than anticipated in February, largely driven by a sharp increase in the cost of fuel imports, according to data released Wednesday by the Labor Department. The report showed import prices climbing 1.3% during the month, following a revised 0.6% increase recorded in January. Economists had projected a more modest…

U.S. stock futures were pointing to a stronger start on Wednesday, suggesting equities could rebound after the modest pullback seen in the previous trading session. Oil prices have retreated following a report from the New York Times stating that the United States has delivered a 15-point proposal to Iran aimed at ending the war in…

Waterdrop Inc. (NYSE:WDH) reported fourth-quarter results that came in above market expectations. The company’s shares rose about 3.59% in after-hours trading following the earnings release. The insurance and healthcare technology platform posted adjusted earnings per share of $0.01 for the quarter, while revenue totaled $201.8 million, representing a 105.5% year-over-year increase from $686.8 million in…